[{"Assets_0_FY_USD":214320000.0,"EarningsPerShareBasic_1_FY_USD":3.75,"EarningsPerShareBasic_4_FY_USD":5.24,"EarningsPerShareDiluted_1_FY_USD":3.52,"EarningsPerShareDiluted_4_FY_USD":4.96,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":53207000.0,"NetIncomeLoss_4_FY_USD":81453000.0,"StockholdersEquity_0_FY_USD":151226000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":16434104.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":15533681.0,"Ticker":"EGRX","CIK":"827871","name":"EAGLE PHARMACEUTICALS, INC.","OfficialName":"Eagle Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"635235963.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170315"}]